000			02111 a2200529 4500
005			20250513170605.0
264		0	_c19990316
008			199903s 0 0 eng d
022			_a0732-183X
024	7		_a10.1200/JCO.1999.17.3.747 _2doi
040			_aNLM _beng _cNLM
100	1		_aHerben, V M
245	0	0	_aPhase I and pharmacologic study of the combination of paclitaxel, cisplatin, and topotecan administered intravenously every 21 days as first-line therapy in patients with advanced ovarian cancer. _h[electronic resource]
260			_bJournal of clinical oncology : official journal of the American Society of Clinical Oncology _cMar 1999
300			_a747-55 p. _bdigital
500			_aPublication Type: Clinical Trial; Clinical Trial, Phase I; Journal Article; Research Support, Non-U.S. Gov't
650	0	4	_aAdult
650	0	4	_aAged
650	0	4	_aAntineoplastic Combined Chemotherapy Protocols _xadverse effects
650	0	4	_aBlood Cell Count
650	0	4	_aCisplatin _xadministration & dosage
650	0	4	_aFatigue _xchemically induced
650	0	4	_aFemale
650	0	4	_aGranulocyte Colony-Stimulating Factor _xadministration & dosage
650	0	4	_aHumans
650	0	4	_aInfusions, Intravenous
650	0	4	_aMiddle Aged
650	0	4	_aNausea _xchemically induced
650	0	4	_aNeoplasm Staging
650	0	4	_aNeutropenia _xchemically induced
650	0	4	_aOvarian Neoplasms _xdrug therapy
650	0	4	_aPaclitaxel _xadministration & dosage
650	0	4	_aThrombocytopenia _xchemically induced
650	0	4	_aTopotecan _xadministration & dosage
700	1		_aPanday, V R
700	1		_aRichel, D J
700	1		_aSchellens, J H
700	1		_avan der Vange, N
700	1		_aRosing, H
700	1		_aBeusenberg, F D
700	1		_aHearn, S
700	1		_aDoyle, E
700	1		_aBeijnen, J H
700	1		_aten Bokkel Huinink, W W
773	0		_tJournal of clinical oncology : official journal of the American Society of Clinical Oncology _gvol. 17 _gno. 3 _gp. 747-55
856	4	0	_uhttps://doi.org/10.1200/JCO.1999.17.3.747 _zAvailable from publisher's website
999			_c10031256 _d10031256